First Leukemia Patient Undergoes Groundbreaking NHS Treatment Describing It as Like Science FictionJanuary 14, 2026
A Bittersweet Goodbye: BioWare’s Destiny-inspired Game Closes Its Doors with Nostalgic FarewellJanuary 12, 2026
Historic Victory: First American Man Claims Chevron Houston Marathon Title Since 2002January 13, 2026
January Rains in Liberia Highlight Deepening Climate Crisis, Warns Environmental AgencyJanuary 13, 2026
Eli Lilly’s Letartortide Achieves Success in First Late-Stage Weight Loss Trial Business December 11, 2025 Eli Lilly announced promising results for its next-generation obesity drug, letaltortide, revealing it achieved the highest weight loss ever recorded…
Eli Lilly and Nvidia Unite to Revolutionize Drug Discovery with AI Supercomputing Business October 29, 2025 Eli Lilly and Nvidia have announced a partnership to create the pharmaceutical industry’s “most powerful” supercomputer and AI factory aimed…
Eli Lilly’s Stock Takes a Dive: Understanding the Decline Business August 7, 2025 Eli Lilly’s shares plummeted 14% after the company reported results for its obesity drug, Orforglipron, which fell short of expectations.…
Eli Lilly Takes Legal Action Against Competitors in Weight Loss Drug Market Business April 24, 2025 Eli Lilly & Co., the manufacturer of the weight loss drug Zepbound, is suing four telehealth companies for allegedly selling…
Eli Lilly Takes Legal Action Against Zepbound Provider Amid Mounjaro Developments Business April 23, 2025 Eli Lilly has initiated legal action against four telehealth companies—Mochi Health, Blow Health, Willow Health, and Henry Med—alleging deceptive practices…
Novo Nordisk’s Wegovy Launch: Implications for Eli Lilly in the Obesity Market Business March 5, 2025 Novo Nordisk has launched Novocare, an online pharmacy where consumers can purchase Wegovy, a weight loss drug, directly from the…